Cell-free DNA-methylation-based methods and applications in oncology

F Galardi, F De Luca, D Romagnoli, C Biagioni… - Biomolecules, 2020 - mdpi.com
Liquid biopsy based on cell-free DNA (cfDNA) enables non-invasive dynamic assessment of
disease status in patients with cancer, both in the early and advanced settings. The analysis …

[HTML][HTML] Recent evidence in epigenomics and proteomics biomarkers for early and minimally invasive diagnosis of Alzheimer's and Parkinson's diseases

S Mayo, J Benito-León, C Peña-Bautista… - Current …, 2021 - ncbi.nlm.nih.gov
Background: Alzheimer's (AD) and Parkinson's diseases (PD) show deposits of improperly
folded modified proteins. Protein expression mechanisms are involved since the early …

Use of DNA methylation profiling in translational oncology

V Ortiz-Barahona, RS Joshi, M Esteller - Seminars in cancer biology, 2022 - Elsevier
DNA methylation is a highly regulated process that has a critical role in human development
and homeostatic control of the cell. The number of genes affected by anomalous DNA …

Epigenetic landscape of liquid biopsy in colorectal cancer

A Rodriguez-Casanova, N Costa-Fraga… - Frontiers in Cell and …, 2021 - frontiersin.org
Colorectal cancer (CRC) is one of the most common malignancies and is a major cause of
cancer-related deaths worldwide. Thus, there is a clinical need to improve early detection of …

Designer Adaptor Proteins for Functional Conversion of Peptides to Small-Molecule Ligands toward In-Cell Catalytic Protein Modification

A Fujimura, H Ishida, T Nozaki, S Terada… - ACS Central …, 2023 - ACS Publications
Peptides are privileged ligands for diverse biomacromolecules, including proteins; however,
their utility is often limited due to low membrane permeability and in-cell instability. Here, we …

Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies

N Hamdani, S Costantino, A Mügge… - European heart …, 2021 - academic.oup.com
Described as the 'single largest unmet need in cardiovascular medicine', heart failure with
preserved ejection fraction (HFpEF) remains an untreatable disease currently representing …

An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression

AA Khan, X Liu, X Yan, M Tahir, S Ali… - Cancer and metastasis …, 2021 - Springer
Pancreatic cancer (PC) is assumed to be an intimidating and deadly malignancy due to
being the leading cause of cancer-led mortality, predominantly affecting males of older age …

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

F Jühling, N Hamdane, E Crouchet, S Li, H El Saghire… - Gut, 2021 - gut.bmj.com
Objective Hepatocellular carcinoma (HCC) is the fastest-growing cause of cancer-related
mortality with chronic viral hepatitis and non-alcoholic steatohepatitis (NASH) as major …

Current paradigms in epigenetic anticancer therapeutics and future challenges

M Singh, V Kumar, N Sehrawat, M Yadav… - Seminars in Cancer …, 2022 - Elsevier
Any alteration at the genetic or epigenetic level, may result in multiplex of diseases including
tumorigenesis which ultimately results in the cancer development. Restoration of the normal …

Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome

R Esteve-Puig, F Climent, D Piñeyro… - Blood, The Journal …, 2021 - ashpublications.org
Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen,
conferring poor clinical outcome | Blood | American Society of Hematology Skip to Main Content …